GATC Health to Speak at the Opioid Settlement Abatement Summit in Washington DC
GATC to highlight its AI-driven addiction solutions to a national audience attending to learn how to allocate the tens of billions of dollars resulting from opioid abatement settlements for states, counties, municipalities and tribes; Dr. Rahul Gupta, director of the Office of National Drug Control Policy, will be the keynote speakers
IRVINE, Calif., Jan. 24, 2023 /PRNewswire/ — GATC Health Corp, a science and technology company revolutionizing drug discovery and disease prediction using artificial intelligence (AI), today announced that Tyrone Lam, COO of GATC Health, will present the company’s fentanyl abatement drug candidates that were identified by GATC’s AI-based drug discovery and development platform. The novel created by GATC are currently in preclinical drug evaluation studies. Guidelines allocated a portion of the Opioid Abatement Settlement funds for research and development, which includes GATC’s opioid addiction abatement projects.
The allocation of opioid settlement funds to states has already begun, yet many states are lagging in their efforts to organize an adequate abatement plan or council to direct and oversee the distribution. The Opioid Settlement Abatement Summit – Model Guidance for States, Counties, Municipalities and Tribes will take place on Thursday January 26th, 2023 at Georgetown University and virtually, and focus on providing model abatement guidance for states, counties, municipalities and tribes to effectively plan for, implement and track opioid settlement funds. The goal of the event is to highlight effective programs, initiatives and tools that are easily adopted and should be considered in state abatement plans as funding begins to come in.
The day-long program will emphasize the importance of ensuring states, counties, municipalities and tribes fully comprehend the unique opportunity they have to ensure that the settlement funds they receive are appropriately used to abate the opioid and overdose crisis in their communities. The program moderator will be Dr. Stephen Loyd, NSUDSAP Advisory Panel member, Chief Medical Officer, Cedar Recovery and Chairman of the Tennessee Abatement Council, along with Dr. Rahul Gupta
GATC Health Corp is a science and technology company revolutionizing disease prediction and drug discovery and development through its transformative AI platform and approach, which de-risks drug pipelines and accelerates new therapies to treat disease with accuracy, efficiency and speed never before achieved in medical science. The company’s validated and proprietary Multiomics Advanced Technology™ (MAT) platform simulates human biochemistry’s billions of interactions for accurate and rapid disease prediction, novel target identification, and drug discovery and development. GATC envisions the future of medicine now, where health is protected, disease is reversed, and every person’s unique biology is treated with precision.
GATC is accelerating the future of predictive, individualized medicine, today.
View original content to download multimedia:https://www.prnewswire.com/news-releases/gatc-health-to-speak-at-the-opioid-settlement-abatement-summit-in-washington-dc-301729908.html
SOURCE GATC Health Corp
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.